Scarica l'app Stockscreener
186.60
0.23%
-0.427
Dopo l'orario di chiusura:
186.50
-0.0971
-0.05%
Precedente Chiudi:
$187.02
Aprire:
$189.12
Volume 24 ore:
3,063
Relative Volume:
0.45
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.23%
1M Prestazione:
-4.37%
6M Prestazione:
+12.60%
1 anno Prestazione:
+15.86%
Intervallo 1D:
$186.49
$189.12
Intervallo di 1 settimana:
$186.49
$194.24
Portata 52W:
$135.34
$202.91
Vaneck Biotech Etf Stock (BBH) Company Profile
Nome
Vaneck Biotech Etf
Settore
Industria
Telefono
-
Indirizzo
-
Compare BBH vs VTI, SPY, IVV, VB, QQQ
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BBH
Vaneck Biotech Etf
|
186.60 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
326.13 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
662.29 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
665.20 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.61 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
593.72 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Biotech Etf Borsa (BBH) Ultime notizie
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps - Bitget
How AI Is Reshaping Drug Discovery and Healthcare Investing - VanEck
Why Is Vertex Pharmaceuticals Stock Soaring Tuesday?Vertex Pharmaceuticals (NASDAQ:VRTX) - Benzinga
Is Investing in the VanEck Biotech ETF (BBH) a Good Choice? - Bitget
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance Singapore
Should You Consider Putting Money into the VanEck Biotech ETF (BBH)? - Bitget
How to Buy iShares Biotechnology ETF (IBB) - The Motley Fool
How to Invest in VanEck Biotech ETF (BBH) - The Motley Fool
True Market-Cap Exposure to Communication Services - VanEck
The top performing pharma and biotech stocks as group sees resurgence (PJP:NYSEARCA) - Seeking Alpha
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money
How AI Is Reshaping Drug Discovery And Healthcare Investing - Seeking Alpha
Best Biotech ETFs to Buy in 2026 - The Motley Fool
Where To Invest $100,000: Japan Stocks, AI, Baseball Cards - Bloomberg.com
Moderna’s rally ripples through biotech and health care ETFs - MSN
Are Healthcare Stocks Poised To Recover As Policy Fears Stabilize? - Seeking Alpha
BBH: Mature Biotech Exposure, But Limited Growth Ahead (NASDAQ:BBH) - Seeking Alpha
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
December Market Recap: Innovation Matures, Constraints Tighten, Money Evolves - VanEck
Nvidia–Eli Lilly Tie-Up Shows Why AI Drug Discovery Is The Next ETF Battleground - Benzinga
Precious Metals Define Commodity Performance in 2025 - VanEck
IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns - Seeking Alpha
Why VanEck Morningstar International Moat ETF stock is upgraded to buyJuly 2025 Macro Moves & Free Community Consensus Stock Picks - ulpravda.ru
Healthcare Stocks In Focus: Assessing The Outlook For 2026 - Seeking Alpha
As Gold Soars, Opportunity Lies in ‘Better, Not Bigger’ Mining Acquisitions - VanEck
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 16.5% - Defense World
How to Buy Gilead Sciences Stock (GILD) - The Motley Fool
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge (NASDAQ:BIIB) - Seeking Alpha
VanEck Biotech ETF declares annual distribution of $0.9565 - MSN
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Day by day downgrades VanEck ETF TrustVanEck Biotech ETF (BBH) - MSN
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
VanEck Mid-December 2025 Bitcoin ChainCheck - VanEck
VanEck Announces Year-End Distributions for VanEck Equity ETFs - Crypto Reporter
Plan for 2026: Predictions from Our Portfolio Managers - VanEck
The Next Phase of Retail: How Consumer Behavior and Technology Are Shaping the Industry - VanEck
Defense Start-ups Galvanize a Once Sleepy Sector - VanEck
5 Best ETFs for Tax-Loss Harvesting | Investing | U.S. News - US News Money
November Market Recap: AI Adoption Surges & Tight Liquidity Creates Opportunity - VanEck
The Fed cut interest rates and bought short-term bonds, Powell leaned dovish, US stocks, short-term US bonds, and gold rose, the dollar fell, while Bitcoin fluctuated. - 富途牛牛
Biotech may still have life - Investment Executive
EDGAR Filing Documents for 0000930413-25-003577 - SEC.gov
How Much More Tightening in EM? - VanEck
Inflation Persistence in EM - VanEck
Yield Advantage: Why EM Local Bonds Are Leading DM Bonds in 2025 - VanEck
Chinese Bonds Offer Yield Pickup - VanEck
AI Revolutionizes Pharma and Biotech Sectors: Market Trends for 2025 - Blockchain News
EM High Yield Corporates: Superior Yields, Low Defaults - VanEck
Vaneck Biotech Etf Azioni (BBH) Dati Finanziari
Non sono disponibili dati finanziari per Vaneck Biotech Etf (BBH). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
1.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):